Φορτώνει......
Survival of Patients with Newly Diagnosed Glioblastoma Treated with Radiation and Temozolomide on Research Studies in the United States
PURPOSE: Novel agents are currently combined with radiation and temozolomide (RT+TMZ) in newly diagnosed glioblastoma using overall survival as the primary endpoint. Results of these phase II studies are typically compared to the phase III EORTC survival data that resulted in RT+TMZ becoming standar...
Αποθηκεύτηκε σε:
Κύριοι συγγραφείς: | , , , , , , |
---|---|
Μορφή: | Artigo |
Γλώσσα: | Inglês |
Έκδοση: |
2010
|
Θέματα: | |
Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2861898/ https://ncbi.nlm.nih.gov/pubmed/20371685 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-09-3106 |
Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|